CTLA4 and hypophysitis: Combinations that involve anti-CTLA-4 drugs, for instance, are especially likely to cause hypophysitis because CTLA-4 is expressed in the cells of the pituitary gland, leading to potentially permanent damage to the glands if it is not immediately identified [114].